Filing Details

Accession Number:
0001437749-23-010871
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-24 09:03:00
Reporting Period:
2023-04-21
Accepted Time:
2023-04-24 09:03:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595248 Genprex Inc. GNPX Pharmaceutical Preparations (2834) 900772347
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1735543 Rodney John Varner 3300 Bee Cave Road
#650-227
Austin TX 78746
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-21 19,000 $1.06 20,800 No 4 P Indirect by Alizzita Ltd
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect by Alizzita Ltd
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,159,735 Direct
Footnotes
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0299 to $1.07 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.